Skip to content

Clinical trials

Observational Pulmonary Disease, Chronic Obstructive trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Observational Country / region: China Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20132
20145
20152
20165
201717
20186
20195
20207
202112
20228
202312
20249
20258
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status42
Completed39
Recruiting17
Active, not recruiting3
Not yet recruiting3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University Third Hospital13
AstraZeneca9
Peking University First Hospital6
Beijing Chao Yang Hospital5
China-Japan Friendship Hospital5
Chinese Academy of Medical Sciences, Fuwai Hospital5
Guangzhou Institute of Respiratory Disease5
GlaxoSmithKline4
West China Hospital3
Boehringer Ingelheim2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive106
Asthma12
Bronchiectasis7
Respiratory Insufficiency5
Disease4
Lung Diseases4
Lung Neoplasms4
Bronchitis3
Lung Diseases, Interstitial3
Pulmonary Embolism3

Trials

Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.